ArticlePain Management in Patients With Cervicogenic HeadacheGevirtz, Clifford MD, MPHAuthor Information Dr. Gevirtz is Clinical Associate Professor, Department of Anesthesiology, Louisiana State University-New Orleans, LA, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: clif[email protected]. Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. He also has disclosed that the use of amitriptyline, gabapentin, tizanidine, baclofen, sublingual nitroglycerin, ergotamine, oxygen inhalation therapy, and methylprednisolone for the management of cervicogenic headache as discussed in this article has not been approved by the U.S. Food and Drug Administration. Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity. Topics in Pain Management: May 2006 - Volume 21 - Issue 10 - p 1-5 Buy CME Test Copyright © 2006 Wolters Kluwer Health, Inc. All rights reserved.